Loading
NT
Neon Therapeutics, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Access Industries Holdings LLC, was filed 03 Jul 2018.
Neon Therapeutics, Inc.: what insiders have been doing
This page follows insider dealings at Neon Therapeutics, Inc. as filed with SEC (Form 4). Neon Therapeutics, Inc. has had no insider filing for more than a year; the last one goes back to 6 May 2020.
Looking back to 2018, when coverage begins, insiders filed 1 purchase and 8 sales.
In the same market, recent insider purchases at GameStop Corp. and Heico Corp also feature in our signals. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
48
Thresholds
n/a
Buy Volume
€4M
1 ops. · all time
Sell Volume
€787,668
8 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2019FY ended December 2019 · cache
Income statement
Net income-71.1M
Last declaration on 6 May 2020
Declarations48 total
196,965 sharesCommon StockSEC:0001694187-20-000063:0
776,085 sharesCommon StockSEC:0001694187-20-000062:0
45,000 sharesCommon StockSEC:0001694187-20-000070:0
134,000 sharesCommon StockSEC:0001694187-20-000068:0
161,821 sharesCommon StockSEC:0001694187-20-000064:0
9,741,636 sharesCommon StockSEC:0001694187-20-000071:0
0Common StockSEC:0001694187-20-000069:0
210,410 sharesCommon StockSEC:0001694187-20-000065:0
117,400 shares@ US$2.202233.8% of flowCommon StockSEC:0001209191-20-021160:0
84,286 shares@ US$2.192324.2% of flowCommon StockSEC:0001209191-20-021160:1
50,358 shares@ US$2.174114.4% of flowCommon StockSEC:0001209191-20-021160:2
9,050 shares@ US$2.51492.9% of flowCommon StockSEC:0001209191-20-020788:1
84,339 shares@ US$2.216124.7% of flowCommon StockSEC:0001209191-20-020788:0
9,783 shares@ US$1.50100.0% of flowCommon StockSEC:0001694187-20-000027:0
4,891 shares@ US$1.5047.1% of flowCommon StockSEC:0001694187-20-000028:0
5,625 shares@ US$1.508.3% of flowCommon StockSEC:0001694187-20-000029:0
2,845 shares@ US$1.5034.3% of flowCommon StockSEC:0001694187-20-000030:0
5,334 shares@ US$1.5165.7% of flowCommon StockSEC:0001694187-20-000013:0
5,465 shares@ US$1.518.2% of flowCommon StockSEC:0001694187-20-000012:0
5,385 shares@ US$1.5152.9% of flowCommon StockSEC:0001694187-20-000014:0
65,000 shares0Common StockSEC:0001694187-20-000006:0
65,000 shares0Common StockSEC:0001694187-20-000008:0
65,000 shares0Common StockSEC:0001694187-20-000005:0
240,000 shares0Common StockSEC:0001694187-20-000007:0
20,000 shares@ US$1.3726.8% of flowCommon StockSEC:0001694187-19-000080:0
25 of 48 declarations
About Neon Therapeutics, Inc.
Neon Therapeutics, Inc. is a biopharmaceutical company focused on developing immuno-oncology therapies. It employs innovative approaches to target tumors through the immune response.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
